BIOTHERYX
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90897381
- Registration number
- 7663077
- Mark type
- Stylized text
- Filed
- 23 Aug 2021
- Published for opposition
- 28 Jun 2022
- Registered
- 21 Jan 2025
- Attorney of record
- Stacey R. Halpern
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, pharmaceutical preparations for restoring protein levels to treat diseases related to aberrant protein expression; none of the foregoing being pharmaceutical preparations for the treatment of anthrax, anthrax vaccines, or vaccines
Owner
- BioTheryX, Inc., San Diego, CA, US
- BioTheryX, Inc., San Diego, CA, US
- BioTheryX, Inc., San Diego, CA, US
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Aug 2024 — USE AMENDMENT FILED
- 25 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2024 — SOU EXTENSION 2 GRANTED
- 14 Feb 2024 — SOU EXTENSION 2 FILED
- 14 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2023 — SOU EXTENSION 1 GRANTED
- 15 Aug 2023 — SOU EXTENSION 1 FILED